相关实验视频
Updated: Jun 11, 2025

11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
54.8K
[针对败血症引起的DIC患者的抗凝剂治疗AI:识别败血症子类的问题和未来方向]
Daisuke Kudo1,2, Shigeki Kushimoto1,2
1Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 2, 2024
概括
鉴定败血症子类对于向治疗至关重要. 这项研究发现,一种特定的抗凝剂仅在一个已识别的败血症子类中改善了生存率,突出了可重复的子类识别的必要性.
科学领域:
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 败血症是一种由感染引起的危及生命的器官功能障碍,其全球发病率和死亡率很高.
- 现有的败血症治疗方法由于患者异质性显著,缺乏特异性.
- 识别不同的败血症子类对于开发有效的向疗法至关重要.
研究的目的:
- 通过识别不同的患者子类来调查败血症异质性.
- 为了确定特定的败血症子类是否对现有治疗有不同的反应.
- 开发用于毒症子类识别的预测模型.
主要方法:
- 对败血症患者数据的分析,以根据凝血特征识别子类.
- 在已识别的子类中评估治疗反应 (复合人体血栓模块素).
- 开发用于败血症子类分配的预测模型.
主要成果:
- 确定了具有不同凝血概况的明显败血症子类.
- 一种特定的抗凝剂 (复合人体血栓模块素) 仅在一个子类中证明了改善生存率.
- 成功开发了一个用于子类识别的预测模型.
结论:
- 败血症异质性需要为个性化治疗策略确定子类.
- 已确定的子类和预测模型需要进一步验证临床实用性.
- 未来的研究应该专注于与病理生理机制相关的可复制子类.
相关概念视频
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
3
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
3
Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
3
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
3
Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3

